Investing Profile

Reza Zadno

VC
President and CEO at Avedro, Inc.
Photo of Reza Zadno, Avedro, Inc.

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Novartis Venture Fund Network
11 CONNECTIONS
cb
10
CompanyStageDateRound SizeTotal Raised
ReVision Optics
Series UnknownNov 2016$32M
Series EJul 2013$55M
Series DJul 2010$35M
$180M
Co-investors: Wende Hutton (Canaan Partners), Brian Dovey (Domain Associates), Bruce Cleveland (Wildcat Ventures), Gil Kliman (InterWest), Renee Compton Ryan (Johnson & Johnson Innovation)
Obalon Therapeutics
Series EMay 2016$16M
Series DJan 2015$20M
Series CJul 2012$17M
$53M
Co-investors: Doug Fisher (InterWest)
Invuity
Private EquityFeb 2015$23M
Series EMar 2014$36M
Series DJun 2012$25M
Series UnknownJan 2012$2M
$86M
Co-investors: Doug Fisher (InterWest)
President and CEO Avedro, Inc.2016 - Present
PhD EducationPresent
PhD Half.comPresent
Materials Research and Product Development Raychem Corporation (Tyco International)Present
Director ( Advanced Development) Cardiac Pathways ( Acquired by Boston Scientific)Present
Genral Manager and Divisional Vice President Abbott Medical OpticsPresent
Innovation Advisor Novartis Venture FundPresent
Special Advisor American Academy of OphthalmologyPresent
Member Board of Directors Half.comPresent
Corporate Strategic Advisor RareSight Inc.Present
Strategic Advisor Horizon Surgical SystemsPresent
Co-Founder and CTO Percusurge, Inc. (Acquired by Medtronic)Present
President and CEO Visiogen, Inc.Present
Founder, President& CEO Visiogen, Inc. ( Acquired by Abbott Medical Optics)Present
Venture Partner New Leaf Venture PartnersPresent
Advisor and Venture Partner InterWest PartnersPresent
President and CEO Glaukos CorporationPresent
President& CEO PROCEPT BioRoboticsPresent
Operating Partner Jolt CapitalPresent
Ecole Nationale Superieure des Mines de Paris PhD (Docteur - Ingénieur)